Vincent Pongia, DPM
Primary Podiatric Medicine · Coatesville, PANPI 1689687204
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 12.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $906 and has fallen 76.1% since, to $216 in 2025.
Across 161 payments — averaging $20.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paratek Pharmaceuticals, Inc.$425
- Convatec Inc.$407
- Smith+Nephew$380
- Bioventus LLC$194
- AbbVie$193
- Aroa Biosurgery Incorporated$164
- plus $2K from 37 others
What the payments were for
- Food & beverage$3,358100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$246
How this compares
$3,360 in reported general payments places this provider in the 80th percentile of 31 primary podiatric medicine providers in Pennsylvania.
See all primary podiatric medicine providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 78 | $2,203 |
| Ketoconazole | 98 | $2,167 |
| Silver Sulfadiazine | 34 | $334 |
| Cephalexin | 58 | $278 |
| Terbinafine Hcl | 19 | $216 |
| Gabapentin | 15 | $145 |
| Methylprednisolone | 27 | $112 |
| SsdSilver Sulfadiazine | 11 | $102 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $95 |
| Tramadol Hcl | 29 | $93 |
| Mupirocin | 12 | $68 |
| Clindamycin Hcl | 13 | $62 |
| Ciprofloxacin Hcl | 11 | $47 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Coatesville
- Donald MrdjenovichAltoona$26K
- Michael DowneyPhiladelphia$9K
- Paul GoehringBeaver Falls$5K
- Carl MattiaYardley$4K
- Louis GreerHarrisburg$3K
- Kenneth D'ortonePhiladelphia$2K
- Ketan KothariPhiladelphia$2K
- Gary CortesePottsville$1K
- Gerald GronborgMc Connellsburg$1K
- Kenneth LefkowitzDoylestown$967
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.